Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF TUMOR-INFILTRATING LYMPHOCYTE IN TREATMENT OF DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/138598
Kind Code:
A1
Abstract:
Use of a tumor-infiltrating lymphocyte in the treatment of diseases, in particular, use of a tumor-infiltrating lymphocyte (TIL) in the preparation of a drug. The drug is used for preventing and/or treating tumors. The TIL is obtained by means of the following culture method: performing at least one stage of in-vitro amplification on a TIL derived from tumor tissue, wherein in a single stage of in-vitro amplification, the in-vitro-amplifed and/or non-in-vitro-amplifed TIL is co-cultured with feeder cells after same comes in contact with a T-cell activator and/or a T-cell growth factor for a certain period of time.

Inventors:
LIU YARONG (CN)
ZHONG MENGYANG (CN)
Application Number:
PCT/CN2023/072784
Publication Date:
July 27, 2023
Filing Date:
January 18, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHOU GRIT BIOTECHNOLOGY CO LTD (CN)
SHANGHAI GRIT BIOTECHNOLOGY CO LTD (CN)
ZHUHAI TUOYU BIOTECHNOLOGY CO LTD (CN)
ZHUHAI GRIT BIOTECHNOLOGY CO LTD (CN)
International Classes:
C12N5/0783; A61K35/17; A61P35/00
Domestic Patent References:
WO2022166947A12022-08-11
WO2022105816A12022-05-27
WO2022135525A12022-06-30
WO2019136459A12019-07-11
WO2021108455A12021-06-03
Foreign References:
CN111601883A2020-08-28
CN106574244A2017-04-19
CN113272421A2021-08-17
US20190008899A12019-01-10
US20200164090A12020-05-28
Other References:
FORGET MARIE-ANDRÉE, TAVERA RENÉ J., HAYMAKER CARA, RAMACHANDRAN RENJITH, MALU SHUTI, ZHANG MINYING, WARDELL SETH, FULBRIGHT ORENT: "A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes", FRONTIERS IN IMMUNOLOGY, vol. 8, XP093079144, DOI: 10.3389/fimmu.2017.00908
Attorney, Agent or Firm:
CHINA SINDA INTELLECTUAL PROPERTY LIMITED (CN)
Download PDF: